- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide
Total 9042 results
-
Merck Sharp & Dohme LLCCompleted
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-positive Breast CancerBrazil
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Lawson Health Research InstituteThe Ottawa HospitalCompleted
-
Georgetown UniversityRecruitingNon-metastatic Breast Cancer | Cancer Related Cognitive DeclineUnited States
-
NSABP Foundation IncGlaxoSmithKlineUnknownInvasive Breast CancerUnited States, Canada, Puerto Rico
-
Instituto Nacional de Cancerologia, ColumbiaUnknown
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
The Netherlands Cancer InstituteActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Dana-Farber Cancer InstituteCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Breast Cancer Research FoundationCompletedBreast CancerUnited States
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
The Greater Poland Cancer CentreActive, not recruiting
-
Shandong Cancer Hospital and InstituteUnknown
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
Peking Union Medical CollegeCSPC Ouyi Pharmaceutical Co., Ltd.Unknown
-
University of Kansas Medical CenterCelgene CorporationCompleted
-
NYU Langone HealthNational Cancer Institute (NCI)Completed
-
NYU Langone HealthCompletedBreast CancerUnited States
-
SanofiCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States, South Africa
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-negative Breast CancerBrazil
-
SanofiCompletedBreast NeoplasmsSpain, Italy, Australia, Czech Republic, Germany, Hungary, Ireland, Israel, New Zealand, Portugal, Slovenia, Slovakia, Austria, Sweden, United Kingdom, Belgium, Brazil, Chile, Denmark, South Africa, Switzerland
-
National Cancer Institute, NaplesWithdrawn
-
Guangdong Provincial People's HospitalUnknown
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHER2+ Early or Locally Advanced Breast Cancer
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...Active, not recruitingBreast Cancer | Neoadjuvant ChemotherapyChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, South Africa
-
German Breast GroupAGO Study GroupCompleted
-
University of ArkansasCompletedBreast Neoplasms | Triple Negative Breast CancerUnited States
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Hospital Universitario Madrid SanchinarroUnknown
-
German Breast GroupAGO Study GroupCompleted
-
PfizerCompleted
-
Herlev HospitalOdense University Hospital; Aarhus University Hospital; Rigshospitalet, DenmarkCompleted
-
Commissie Voor Klinisch Toegepast OnderzoekUnknownLung CancerNetherlands
-
National Cancer Centre, SingaporeTerminated
-
Cancer Institute and Hospital, Chinese Academy...CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting